There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for MIRA is 9.75M and currently, short sellers hold a 0.17% ratio of that float. The average trading volume of MIRA on July 26, 2024 was 4.57M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
MIRA) stock’s latest price update
The stock price of Mira Pharmaceuticals Inc (NASDAQ: MIRA) has jumped by 1.64 compared to previous close of 3.04. Despite this, the company has seen a gain of 348.61% in its stock price over the last five trading days. accesswire.com reported 2024-07-25 that Latest positive preclinical data provides another step in the path to potential IND submission this year for novel ketamine analog MIAMI, FL / ACCESSWIRE / July 25, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) (“MIRA” or the “Company”), a leading pre-clinical-stage pharmaceutical company, today announced new insights garnered from additional, recently received preclinical study data regarding the mechanism of action and toxicology data for its novel oral ketamine analog, Ketamir-2. Ketamir-2 is MIRA’s drug candidate being investigated as a potential treatment for neurological and neuropsychiatric disorders.
MIRA’s Market Performance
MIRA’s stock has risen by 348.61% in the past week, with a monthly rise of 338.30% and a quarterly rise of 243.33%. The volatility ratio for the week is 98.15% while the volatility levels for the last 30 days are 33.92% for Mira Pharmaceuticals Inc The simple moving average for the past 20 days is 164.53% for MIRA’s stock, with a 123.43% simple moving average for the past 200 days.
MIRA Trading at 230.85% from the 50-Day Moving Average
After a stumble in the market that brought MIRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -61.28% of loss for the given period.
Volatility was left at 33.92%, however, over the last 30 days, the volatility rate increased by 98.15%, as shares surge +346.15% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +292.79% upper at present.
During the last 5 trading sessions, MIRA rose by +321.02%, which changed the moving average for the period of 200-days by -33.03% in comparison to the 20-day moving average, which settled at $1.28. In addition, Mira Pharmaceuticals Inc saw 194.29% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MIRA starting from Aminov Erez, who purchase 8,700 shares at the price of $0.94 back on May 21 ’24. After this action, Aminov Erez now owns 382,200 shares of Mira Pharmaceuticals Inc, valued at $8,176 using the latest closing price.
McNulty Brian Patrick, the 10% Owner of Mira Pharmaceuticals Inc, sale 46,005 shares at $1.55 during a trade that took place back on Dec 11 ’23, which means that McNulty Brian Patrick is holding 660,000 shares at $71,496 based on the most recent closing price.
Stock Fundamentals for MIRA
The total capital return value is set at -2.84. Equity return is now at value -1807.80, with -587.64 for asset returns.
Based on Mira Pharmaceuticals Inc (MIRA), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -4404.34. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is -2.55.
Currently, EBITDA for the company is -8.53 million with net debt to EBITDA at 0.39. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.70.
Conclusion
In conclusion, Mira Pharmaceuticals Inc (MIRA) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
